Search Results 231-240 of 17008 for pharmacogenetics
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Learn about genetic studies of cognition risks related to Alzheimer's disease in in Mayo Clinic's Precision Medicine in Neurodegeneration Lab led by Nilufer ...
Mayo Clinic's Keith D. Robertson, Ph.D., focuses on determining how normal cells establish and maintain epigenetic marks, especially DNA and histone ...
From fighting cancer to opioid addiction: Genetics matter with medications featured image · 5 new ways health care providers can apply individualized medicine to ...
The role of pharmacogenetics in personalizing the antidepressant and anxiolytic therapy. Genes. 2023; doi:10.3390/genes14051095. Henssler J, et al ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.
Latest stories · Immune response to ovarian cancer may predict survival, Mayo-led study finds featured image · From fighting cancer to opioid addiction: Genetics ...
The purpose of this study is to develop an AI-driven biomarker based on FDG-PET images to track longitudinal brain changes in asymptomatic (n = 15) and ...
About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...
The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research samples ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.